Why AstraZeneca Covid-19 vaccine approval 'good news for whole world'? UK minister...

The Phase 3 trials of AstraZeneca’s vaccine across two different dose regimens showed an average efficacy of 70.4%, with no hospitalisations or severe disease observed in the vaccinated groups from three weeks after the first dose.

from Hindustan Times - world https://ift.tt/2WXNlSi